CIBENZOLINE PLASMA-CONCENTRATION AND ANTIARRHYTHMIC EFFECT

被引：44

作者：

BRAZZELL, RK

AOGAICHI, K

HEGER, JJ

SOMBERG, JC

CARLINER, NH

MORGANROTH, J

机构：

[1] INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202

[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461

[3] UNIV MARYLAND,SCH MED,BALTIMORE,MD 21201

[4] VET ADM MED CTR,BALTIMORE,MD 21218

[5] HAHNEMANN UNIV,LIKOFF CARDIOVASC INST,PHILADELPHIA,PA 19102

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 35卷 / 03期

关键词：

D O I：

10.1038/clpt.1984.35

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：307 / 316

页数：10

相关论文

共 13 条

[1] BRAZZELL RK, UNPUB CLIN PHARM THE
[2] THERAPEUTIC DRUG-MONITORING OF ANTIARRHYTHMIC AGENTS
BROWN, JE
SHAND, DG
[J]. CLINICAL PHARMACOKINETICS, 1982, 7 (02) : 125 - 148
[3] PHARMACOKINETICS IN MAN OF A NEW ANTI-ARRHYTHMIC DRUG, CIBENZOLINE
CANAL, M
FLOUVAT, B
TREMBLAY, D
DUFOUR, A
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (04) : 509 - 515
[4] SIMULTANEOUS PHARMACOKINETIC AND PHARMACODYNAMIC MODELING
COLBURN, WA
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (03): : 367 - 388
[5] PHARMACOLOGY OF COMMONLY USED ANTIARRHYTHMIC DRUGS AND COMMENTS ON THE USE OF THERAPEUTIC DRUG-MONITORING
GARFEIN, OB
[J]. THERAPEUTIC DRUG MONITORING, 1982, 4 (01) : 1 - 14
[6] DETERMINATION OF CIBENZOLINE IN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
HACKMAN, MR
LEE, TL
BROOKS, MA
[J]. JOURNAL OF CHROMATOGRAPHY, 1983, 273 (02): : 347 - 356
[7] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS
HOLFORD, NHG
SHEINER, LB
[J]. CLINICAL PHARMACOKINETICS, 1981, 6 (06) : 429 - 453
[8] THERAPEUTIC MONITORING OF ANTI-ARRHYTHMIC DRUGS
KATES, RE
[J]. THERAPEUTIC DRUG MONITORING, 1980, 2 (02) : 119 - 126
[9] PROCAINAMIDE DOSAGE SCHEDULES, PLASMA CONCENTRATIONS, AND CLINICAL EFFECTS
KOCHWESER, J
KLEIN, SW
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (09) : 1454 - +
[10] MEFFIN PJ, 1977, CLIN PHARMACOL THER, V22, P42